Drug profile · INN
elagolix sodium
ORILISSA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
elagolix sodium (ORILISSA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN elagolix sodium
Brand ORILISSA
Route ORAL
Formulation TABLET
Frequently asked questions
What is elagolix sodium?
elagolix sodium (ORILISSA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for elagolix sodium?
ORILISSA is a marketed brand name for elagolix sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of elagolix sodium?
elagolix sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.